As the new year approaches, we look back with gratitude for yet another year packed with scientific breakthroughs in children’s health. Continuing a remarkable run for personalized gene therapies, 2018 marked the European Commission’s approval of two gene therapies pioneered at Children’s Hospital of Philadelphia and the University of Pennsylvania, as patients in the European Union (EU) may now be treated with chimeric antigen receptor (CAR)-T cell therapy for aggressive forms of leukemia, and the very first gene therapy developed for inherited blindness.
Tag Archive: Matthew Weitzman
Six students from local under-resourced schools eagerly swapped sunglasses for safety goggles and got to work this summer in some of the most sophisticated research laboratories on campus at Children’s Hospital of Philadelphia Research Institute.
The students navigated real-world research settings, practiced lab skills, explored scientific and medical career options, and met mentors who are dedicated to advancing pediatric medicine, as part of the six-week CHOP Research Internship for Scholars and Emerging Scientists (CHOP-RISES) summer internship. The new program is offered by the Office of Academic Training and Outreach Programs (ATOP) at the Research Institute.
“What does Children’s Hospital of Philadelphia do to support you as postdocs, and how can we do better?” That was the key question addressed at the first-ever Annual Postdoctoral Fellow Town Hall, hosted by the Office of Postdoctoral Affairs (OPA) at the Research Institute June 20.
Taking the form of a Q&A panel session, the event gathered postdoctoral scholars across diverse departments of the Research Institute along with administrative and faculty leaders who direct research support and training programs. The goal: Hear from our talented and hard-working fellows on how the Research Institute can help to propel them toward a future of breakthroughs.
It was a big year for children’s health: We celebrated the U.S. Food and Drug Administration’s approval of the world’s first chimeric antigen receptor (CAR)-T cell therapy this September, followed closely by approval of the very first gene therapy to treat inherited blindness this month — both of which have their roots at Children’s Hospital of Philadelphia and the University of Pennsylvania. But besides the big headline-making breakthroughs (brilliant as they are), we wanted to know what other stories captivated our readers in 2017.
Our research trainees at Children’s Hospital of Philadelphia go on to treat, teach, and investigate at some of the best medical institutions in the world. As the next generation of pediatric scientists, the mentors they meet while at CHOP don’t just influence their careers, but the future of children’s health, too.
Adenovirus, a common human virus that usually affects the lungs and causes respiratory tract infections, is an old friend to virologists. They have long studied how this virus interacts with host cells to understand cellular processes and reveal key regulators of cellular functions.